BILASTINE ZENTIVA 20 mg, tablet 30 tablets
Active ingredients: Bilastine, Bilastine monohydrate
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BILASTINE ZENTIVA 20 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 30 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 May 2026
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60202750CIP73022853CIP133400930228531Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BILASTINEcomprimé | 20 mg · un comprimé | FT |
| BILASTINE MONOHYDRATÉEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.